Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for prevention of new vertebral compression fractures after vertebral augmentation
ChiCTR-TNRC-09000478Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alendronate in osteoporosis (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Rate of new adjacent vertebral compression fractures and Rate of new vertebral compression fractures. Started Jan 2015; status: completed.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on ChiCTR-TNRC-09000478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNRC-09000478.